{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:28:45Z","timestamp":1793021325304,"version":"4.5.0"},"reference-count":39,"publisher":"American Psychiatric Association Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FOC"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1176\/appi.focus.26024113","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:00:19Z","timestamp":1776225619000},"page":"223-235","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study"],"prefix":"10.1176","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0507-9033","authenticated-orcid":false,"given":"Colette","family":"Kosik-Gonzalez","sequence":"first","affiliation":[{"name":"Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-0743","authenticated-orcid":false,"given":"Dong-Jing","family":"Fu","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5582-4941","authenticated-orcid":false,"given":"Li Nancy","family":"Chen","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3373-3985","authenticated-orcid":false,"given":"Rosanne","family":"Lane","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0352-4080","authenticated-orcid":false,"given":"Michael H.","family":"Bloch","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1837-4126","authenticated-orcid":false,"given":"Melissa","family":"DelBello","sequence":"additional","affiliation":[{"name":"University of Cincinnati College of Medicine, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0541-4846","authenticated-orcid":false,"given":"Carmen","family":"Moreno","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-3930","authenticated-orcid":false,"given":"Wayne C.","family":"Drevets","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC, a Johnson & Johnson company, San Diego, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6817-9105","authenticated-orcid":false,"given":"Carla M.","family":"Canuso","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.su7102a1"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199809000-00011"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamapsychiatry.55"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-018-01270-9"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1037\/a0014732"},{"issue":"1060","key":"e_1_3_4_7_2","first-page":"44","article-title":"Psychiatric illness in a New Zealand sample of young people making serious suicide attempts","volume":"111","author":"Beautrais AL","year":"1998","unstructured":"Beautrais AL, Joyce PR, Mulder RT. Psychiatric illness in a New Zealand sample of young people making serious suicide attempts. N Z Med J. 1998;111(1060):44-48.","journal-title":"N Z Med J"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199912000-00010"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830040075012"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.07m03904"},{"key":"e_1_3_4_11_2","volume-title":"Treatment for Suicidal Ideation, Self-Harm, and Suicide Attempts Among Youth","author":"Substance Abuse and Amental Health Services Administration (SAMHSA)","year":"2020","unstructured":"Substance Abuse and Amental Health Services Administration (SAMHSA). Treatment for Suicidal Ideation, Self-Harm, and Suicide Attempts Among Youth. SAMHSA Publication No. PEP20-06-01-002. Rockville, MD: Substance Abuse and Mental Health Services Administration. 2020. Accessed May 24, 2024. https:\/\/store.samhsa.gov\/sites\/default\/files\/pep20-06-01-002.pdf"},{"key":"e_1_3_4_12_2","volume-title":"Depression in children and young people: identification and management","year":"2019","unstructured":"Depression in children and young people: identification and management. NICE guideline [NG134]. National Institute for Health and Care Excellence; 2019. Accessed April 21, 2025. https:\/\/www.nice.org.uk\/guidance\/ng134"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2011.06.003"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2022.10.001"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.7.1029"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.1044"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.76.1.92"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19m13191"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaa068"},{"key":"e_1_3_4_20_2","volume-title":"Spravato (Esketamine) Nasal Spray","year":"2025","unstructured":"Spravato (Esketamine) Nasal Spray. Prescribing Information. Titusville, NJ: Janssen Pharmaceutical Companies; January 2025. Accessed April 21, 2025. https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/SPRAVATO-pi.pdf"},{"key":"e_1_3_4_21_2","volume-title":"Esketamine nasal spray. Summary of product characteristics","year":"2025","unstructured":"Esketamine nasal spray. Summary of product characteristics. European Medicines Agency; January 23, 2025. Accessed April 21, 2025. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/spravato-epar-product-information_en.pdf"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05305whi"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198403000-00011"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"issue":"4","key":"e_1_3_4_26_2","first-page":"36","article-title":"SIBAT-A computerized assessment tool for suicide ideation and behavior: development and psychometric properties","volume":"19","author":"Alphs L","year":"2022","unstructured":"Alphs L, Fu DJ, Williamson D, et al. SIBAT-A computerized assessment tool for suicide ideation and behavior: development and psychometric properties. Innov Clin Neurosci. 2022;19(4-6):36-47.","journal-title":"Innov Clin Neurosci"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024465317902"},{"issue":"4","key":"e_1_3_4_28_2","first-page":"244","article-title":"Validity and reliability of the Observers Assessment of Alertness\/Sedation Scale: study with intravenous midazolam","volume":"10","author":"Chernik DA","year":"1990","unstructured":"Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observers Assessment of Alertness\/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10(4):244-251.","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"e_1_3_4_30_2","first-page":"227","article-title":"A Brief Psychiatric Rating Scale (BPRS) expanded version: scales, anchor points and administration manual.","volume":"3","author":"Ventura J","year":"1993","unstructured":"Ventura J, Lukoff D, Nuechterlein KH, Liberman RP, Green MF, Shaner A. A Brief Psychiatric Rating Scale (BPRS) expanded version: scales, anchor points and administration manual. Int J Methods Psychiatr Res. 1993;3:227-243.","journal-title":"Int J Methods Psychiatr Res"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31817efbac"},{"key":"e_1_3_4_33_2","volume-title":"NSU Florida Guided Self-Change","author":"The Timeline Followback (TLFB)","unstructured":"The Timeline Followback (TLFB). NSU Florida Guided Self-Change. Accessed April 21, 2025. https:\/\/www.nova.edu\/timeline\/index.html"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.17060720"},{"issue":"5","key":"e_1_3_4_35_2","first-page":"CD013674","article-title":"New generation antidepressants for depression in children and adolescents: a network meta-analysis","volume":"5","author":"Hetrick SE","year":"2021","unstructured":"Hetrick SE, McKenzie JE, Bailey AP, et al. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021;5(5):CD013674. https:\/\/doi.org\/10.1002\/14651858.CD013674.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.64719\/pb.4412"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0317-8"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp-rj.2022.170401"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20010018"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2023.05.031"}],"container-title":["Focus"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:00:34Z","timestamp":1776225634000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.focus.26024113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1176\/appi.focus.26024113"],"URL":"https:\/\/doi.org\/10.1176\/appi.focus.26024113","relation":{},"ISSN":["1541-4094","1541-4108"],"issn-type":[{"value":"1541-4094","type":"print"},{"value":"1541-4108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}